The Breathalyzers Market was valued at $3.19 billion in 2023. It is projected to reach $10.99 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 16.7% from 2024 to 2031.

The Brain Tumor Drugs Market was valued at USD 2.9 billion in 2022 and is projected to reach USD 5.73 billion by 2030, growing at a CAGR of 8.9% over the forecast period from 2022 to 2030.

The Brain Tumor Drugs Market was valued at USD 2.9 billion in 2022 and is projected to reach USD 5.73 billion by 2030, growing at a CAGR of 8.9% over the forecast period from 2022 to 2030.

The Bovine Mastitis Market size was valued at USD 0.60 billion in 2023 and is projected to reach USD 0.98 billion by 2031, growing at a CAGR of 6.4% over the forecast period from 2024 to 2031.

The Bovine Mastitis Market size was valued at USD 0.60 billion in 2023 and is projected to reach USD 0.98 billion by 2031, growing at a CAGR of 6.4% over the forecast period from 2024 to 2031.

The Bone Densitometer Market was valued at USD 314.1 million in 2023 and is projected to grow to USD 453.5 million by 2031, at a CAGR of 4.7% during the forecast period from 2024 to 2031.

The Bone Densitometer Market was valued at USD 314.1 million in 2023 and is projected to grow to USD 453.5 million by 2031, at a CAGR of 4.7% during the forecast period from 2024 to 2031.

The Blood Transfusion Diagnostics Market was valued at approximately USD 4.70 billion in 2022 and is projected to reach USD 8.38 billion by 2030, growing at a compound annual growth rate (CAGR) of around 7.2%

The Blood Screening Market was valued at USD 3.02 billion in 2023 and is anticipated to grow to USD 7.37 billion by 2031, expanding at a CAGR of 11.8% during the forecast period from 2024 to 2031.

The Bladder Cancer Detection Kit Market was valued at USD 0.112 billion in 2023 and is projected to reach USD 0.23 billion by 2031, growing at a CAGR of 9.93% during the forecast period from 2024 to 2031.

The Bispecific Antibodies Market was valued at $8.24 billion in 2023. It is projected to grow to $153.23 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 44.1% from 2024 to 2031.

The Bio Decontamination Market was valued at USD 225 million in 2022 and is projected to grow to USD 410.3 million by 2030, reflecting a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2030.

The Autoimmune Disease Testing Market size was valued at USD 11.24 billion in 2023 and is expected to reach approximately USD 24.14 billion by 2031, growing at a remarkable CAGR of 10.27% over the forecast period 2024-2031.

The global autoimmune disease therapeutics market was valued at USD 72.05 billion in 2022 and is projected to reach USD 94.87 billion by 2030, registering a compound annual growth rate (CAGR) of 3.5% during the forecast period from 2023 to 2030.